Tucatinib

Empowering Breast Cancer Treatment

Molecular Name: Tucatinib
Active Ingredient: Tucatinib
Strength: 50 mg/tablet and 150 mg/tablet
Manufacturer Name: Genentech

List of excipients:

  • Lactose monohydrate
  • Microcrystalline cellulose
  • Hypromellose
  • Magnesium stearate
  • Colloidal silicon dioxide
  • Titanium dioxide (E171)
  • Yellow iron oxide (E172)
More Information
website background
Doctor

Why is Kineret injection prescribed?

The prescription medicine KINERET (anakinra), commonly known as an interleukin-1 receptor antagonist (IL-1Ra), is only available to adults over the age of 18 to:

  • Reduce the signs and symptoms of moderate to severe active rheumatoid arthritis (RA) and slow the damage it causes.
  • To treat people with a form of Cryopyrin-Associated Periodic Syndromes (CAPS) called Neonatal-Onset Multisystem Inflammatory Disease (NOMID)
  • To treat people with Deficiency of Interleukin-1 Receptor Antagonist (DIRA)

To administer Kineret, a subcutaneous injection is used.

Kineret is provided in a graduated prefilled syringe and is ready for use. Using the graduated prefilled syringe, doses between 20 and 100 mg are possible. The syringe is inappropriate for pediatric patients with a body weight below 10 kg because the minimum dose is 20 mg.

Who should not take KINERET?

  • Individuals with allergies to proteins produced by the E. coli bacteria.
  • Individuals with allergies to any component of KINERET, including anakinra. A complete list of KINERET's ingredients can be seen at the end of the patient information sheet.
  • Women who are pregnant or breastfeeding.

If you’re unsure, speak with your doctor.

What are the possible side effects of KINERET?

Severe possible side effects of KINERET include:

  • Allergic reactions
  • Fever or chills
  • Headache
  • Nausea and Vomiting
  • Diarrhea
  • Joint pain
  • Fever
  • Feeling like you have the flu
  • Sore throat or runny nose
  • Sinus infection
  • Redness, Bruising, Swelling, and Pain
  • Urinary tract infection
  • Pain in your stomach area

What documents are required to import KINERET to Dubai?

Individual Patients or hospitals may import Kineret 100 mg at a reasonable price
The following paperwork is necessary to import:
  • An authentic prescription from a licensed physician.
  • Diagnostic reports for patients
  • Patients id proof (Certificate of Origin)

Special Precautions For Kineret

  • Anakinra is sold in graduated prefilled syringes at a reasonable injection cost.
  • Kineret is a sterile, unpreserved fluid. For one use only.
  • Keep in the refrigerator at 2 to 8 degrees Celsius.
  • Avoid freezing.
  • To protect against light, keep it in the original container.
  • The prefilled syringe shouldn't be shaken.
  • For ambulatory use, Kineret may be left out of the fridge for up to 12 hours at a temperature no higher than 25 °C without going past the expiration date.
  • The product must be thrown off once this time has passed instead of returning it to the refrigerator.
  • Before using the solution, visually inspect it for contaminants and discolouration.
  • It is only advised to inject transparent, colourless to white solutions that may contain a few translucent to white amorphous particles from the substance itself.
  • The existence of these particles has no impact on the product's quality.
  • Following local legislation, waste and unneeded pharmaceuticals should be disposed of.

Tucatinib is a prescription medication used to treat adult patients with HER2-positive breast cancer that is locally advanced or metastatic (has spread to other parts of the body). Tucatinib is taken in combination with trastuzumab and capecitabine.

Special storage precautions:

· Tucatinib should be stored at room temperature (between 68°F and 77°F) in a tightly   closed container.

· Tucatinib should not be stored in the bathroom or near a heat source.

· Tucatinib should be stored in the original carton to protect it from light.

Key Features:

· Tucatinib is a targeted therapy that works by blocking the HER2 protein, which is found on the surface of cancer cells.

· Tucatinib has been shown to significantly improve the progression-free survival (PFS) of patients with HER2-positive breast cancer.

· Tucatinib is generally well-tolerated, with the most common side effects being diarrhea, nausea, vomiting, and hand-foot syndrome.

Specifications:

· Tucatinib is available as film-coated tablets in two strengths: 50 mg and 150 mg.

· The recommended dosage of Tucatinib is 300 mg taken orally twice daily in combination with trastuzumab and capecitabine.

· Tucatinib should be taken with food.

· Tucatinib is not recommended for patients with severe liver impairment.

Usage Guidelines:

· Tucatinib should be taken under the supervision of a healthcare professional.

· Patients should read the Tucatinib Medication Guide carefully before starting treatment.

· Patients should tell their healthcare professional about all of their medical conditions, including allergies, other medications they are taking, and their pregnancy plans.

· Patients should monitor their weight and report any changes to their healthcare professional.

· Patients should contact their healthcare professional immediately if they experience any serious side effects.

About Us

We are a leading pharmaceutical wholesaler, Hayat Alhikmah, situated in Dubai. By providing generic medications, reference listed drugs, name patient import services, and temperature-controlled products simple to access for our consumers, we help them overcome geographic distances.


We offer affordable access to anakinra injection in Dubai with ease and speed. Depending on the customer’s needs, we provide a quality guarantee and shipping anywhere in the world.

Please schedule a consultation with us by calling us at +971 54 777 1238  or email us at [email protected] to know how much anakinra injection costs in Dubai. Our helpful team would be happy to assist you and provide any general or medical information.

0 +

Distributors

0 +

Ware House

0 +

Awards

FAQ's

Tucatinib should not be taken by patients with severe liver impairment. Tucatinib should also be avoided by patients who are allergic to tucatinib or any of the ingredients in Tucatinib.

Tucatinib should be stored at room temperature (between 68°F and 77°F) in a tightly closed container. Tucatinib should not be stored in the bathroom or near a heat source.

Tucatinib has been shown to significantly improve the progression-free survival (PFS) of patients with HER2-positive breast cancer that is locally advanced or metastatic. In a clinical study, Tucatinib-treated patients had a median PFS of 16.4 months, compared to 9.3 months for patients who received placebo.

Tucatinib is taken orally twice daily in combination with trastuzumab and capecitabine. The recommended dosage of Tucatinib is 300 mg.

Tucatinib can cause serious side effects, including diarrhea, nausea, vomiting, and hand-foot syndrome. Other side effects that may occur with Tucatinib include:

  • Fatigue
  • Headache
  • Constipation
  • Rash
  • Dry skin
  • Decreased appetite
  • Weight loss
  • Changes in taste
  • Changes in vision
  • Decreased white blood cell count
  • Increased liver enzymes
  • Decreased kidney function